N
Nasus Pharma Ltd
NSRXCIK 0002029039NYSENon-AcceleratedEmerging GrowthPharmaceutical PreparationsL3ILFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$-5.86M
Total Assets
$5.00M
Equity
$2.77M
Shares Out
9.02M
Op. Cash Flow
$-4.92M
Business
Nasus Pharma Ltd is a foreign private issuer in Pharmaceutical Preparations, headquartered in Israel. Shares trade on NYSE under the ticker NSRX.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-5.86M |
| Total assets | $5.00M |
| Total liabilities | $2.24M |
| Stockholders' equity | $2.77M |
| Operating cash flow | $-4.92M |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro